Typically, the goal of ALS treatments is to slow the disease or halt progression. But new data from the antisense oligonucleotide (ASO) jacifusen for FUS-ALS show that two patients went beyond the ...
MedPage Today on MSN
ALS testing expected to drive sharp rise in clinic visits
Genetic screening in the wake of new therapies will identify more at-risk relatives ...
Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK DRI) at King’s College London have managed to identify a common ...
Gene-targeted testing is projected to increase the number of amyotrophic lateral sclerosis (ALS) clinic visits for risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results